KindlyMD (NASDAQ:NAKA) Announces Earnings Results

KindlyMD (NASDAQ:NAKA) issued its quarterly earnings results on Thursday. The company reported ($6.65) EPS for the quarter, FiscalAI reports. KindlyMD had a negative return on equity of 81.32% and a negative net margin of 7,397.12%.The business had revenue of $35.87 million during the quarter.

KindlyMD Stock Performance

NASDAQ:NAKA traded down $0.12 during trading hours on Friday, hitting $4.93. 41,883 shares of the company’s stock traded hands, compared to its average volume of 195,519. The stock’s fifty day moving average price is $4.37 and its two-hundred day moving average price is $7.58. The firm has a market cap of $85.78 million, a P/E ratio of -0.11 and a beta of 15.95. KindlyMD has a twelve month low of $3.33 and a twelve month high of $624.00.

Analyst Ratings Changes

Several analysts recently commented on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of KindlyMD in a research note on Friday, August 7th. Wall Street Zen raised KindlyMD to a “sell” rating in a report on Saturday, May 23rd. Finally, TD Cowen increased their price objective on KindlyMD from $1.00 to $17.00 and gave the company a “buy” rating in a research report on Monday, July 27th. Three analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $22.33.

Insider Buying and Selling

In other KindlyMD news, CEO David F. Bailey bought 55,115 shares of the stock in a transaction on Thursday, May 28th. The shares were bought at an average price of $5.62 per share, with a total value of $309,746.30. Following the purchase, the chief executive officer directly owned 3,175,476 shares in the company, valued at $17,846,175.12. The trade was a 1.77% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In the last three months, insiders bought 191,448 shares of company stock worth $992,908. Company insiders own 24.49% of the company’s stock.

Institutional Trading of KindlyMD

Hedge funds and other institutional investors have recently modified their holdings of the company. SG Americas Securities LLC acquired a new stake in KindlyMD during the fourth quarter valued at $61,000. Virtu Financial LLC acquired a new stake in KindlyMD in the fourth quarter valued at approximately $151,000. J. Derek Lewis & Associates Inc. bought a new position in shares of KindlyMD during the 4th quarter valued at $167,000. Truist Financial Corp acquired a new stake in shares of KindlyMD in the 4th quarter valued at $176,000. Finally, Waddell & Associates LLC acquired a new stake in shares of KindlyMD in the 4th quarter valued at $201,000.

About KindlyMD

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.